 | • レポートコード：MRC2-11QY04981 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、129ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療機器・消耗品 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は血管炎治療のグローバル市場について調査・分析したレポートです。種類別（大型船、中型船、小型船）市場規模、用途別（病院・診療所、診断センター、研究所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別血管炎治療の競争状況、市場シェア ・世界の血管炎治療市場：種類別市場規模 2015年-2020年（大型船、中型船、小型船） ・世界の血管炎治療市場：種類別市場規模予測 2021年-2026年（大型船、中型船、小型船） ・世界の血管炎治療市場：用途別市場規模 2015年-2020年（病院・診療所、診断センター、研究所、その他） ・世界の血管炎治療市場：用途別市場規模予測 2021年-2026年（病院・診療所、診断センター、研究所、その他） ・北米の血管炎治療市場分析：米国、カナダ ・ヨーロッパの血管炎治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの血管炎治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の血管炎治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの血管炎治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbvie、Ablynx、Amgen、Anthera Pharmaceuticals、Aspen Pharmacare Holdings、Astrazeneca、Baxter、Biogen、Bristol-Myers Squibb、Celgene、Celltrion、Chemocentryx、Chugai Pharma Usa、Eisai、Eli Lilly、F. Hoffmann-La Roche、Genentech、Gilead、Glaxosmithkline、Human Genome Sciences ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Vasculitis is a general term that refers to inflammation of blood vessels. When blood vessels become inflamed, they may become weakened, stretch, and either increase in size or become narrow — even to the point of closing entirely. Vasculitis can affect people of all ages, but there are types of vasculitis that occur in certain age groups more often than others.
The market for vasculitis across the globe is expected to propel significantly during the forecast period. The factors driving the vasculitis market are rising incidences of metabolic disorders and circulatory diseases such as peripheral arterial disease (PAD) and high demand for minimally invasive procedures. In addition, the rising healthcare expenditure and R&D vasculitis treatment and supportive reimbursement policies are estimated to impact the market positively during the forecast period.
Market Analysis and Insights: Global Vasculitis Treatment Market
The global Vasculitis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Vasculitis Treatment Scope and Market Size
Vasculitis Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Vasculitis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbvie
Ablynx
Amgen
Anthera Pharmaceuticals
Aspen Pharmacare Holdings
Astrazeneca
Baxter
Biogen
Bristol-Myers Squibb
Celgene
Celltrion
Chemocentryx
Chugai Pharma Usa
Eisai
Eli Lilly
F. Hoffmann-La Roche
Genentech
Gilead
Glaxosmithkline
Human Genome Sciences
Market segment by Type, the product can be split into
Large Vessels
Medium Vessels
Small Vessels
Market segment by Application, split into
Hospitals And Clinics
Diagnosis Center
Research Institutes
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Vasculitis Treatment Revenue
1.4 Market by Type
1.4.1 Global Vasculitis Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Large Vessels
1.4.3 Medium Vessels
1.4.4 Small Vessels
1.5 Market by Application
1.5.1 Global Vasculitis Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals And Clinics
1.5.3 Diagnosis Center
1.5.4 Research Institutes
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Vasculitis Treatment Market Perspective (2015-2026)
2.2 Global Vasculitis Treatment Growth Trends by Regions
2.2.1 Vasculitis Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Vasculitis Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Vasculitis Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Vasculitis Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Vasculitis Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Vasculitis Treatment Players by Market Size
3.1.1 Global Top Vasculitis Treatment Players by Revenue (2015-2020)
3.1.2 Global Vasculitis Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Vasculitis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Vasculitis Treatment Market Concentration Ratio
3.2.1 Global Vasculitis Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Vasculitis Treatment Revenue in 2019
3.3 Vasculitis Treatment Key Players Head office and Area Served
3.4 Key Players Vasculitis Treatment Product Solution and Service
3.5 Date of Enter into Vasculitis Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Vasculitis Treatment Historic Market Size by Type (2015-2020)
4.2 Global Vasculitis Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Vasculitis Treatment Market Size by Application (2015-2020)
5.2 Global Vasculitis Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Vasculitis Treatment Market Size (2015-2020)
6.2 Vasculitis Treatment Key Players in North America (2019-2020)
6.3 North America Vasculitis Treatment Market Size by Type (2015-2020)
6.4 North America Vasculitis Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Vasculitis Treatment Market Size (2015-2020)
7.2 Vasculitis Treatment Key Players in Europe (2019-2020)
7.3 Europe Vasculitis Treatment Market Size by Type (2015-2020)
7.4 Europe Vasculitis Treatment Market Size by Application (2015-2020)
8 China
8.1 China Vasculitis Treatment Market Size (2015-2020)
8.2 Vasculitis Treatment Key Players in China (2019-2020)
8.3 China Vasculitis Treatment Market Size by Type (2015-2020)
8.4 China Vasculitis Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Vasculitis Treatment Market Size (2015-2020)
9.2 Vasculitis Treatment Key Players in Japan (2019-2020)
9.3 Japan Vasculitis Treatment Market Size by Type (2015-2020)
9.4 Japan Vasculitis Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Vasculitis Treatment Market Size (2015-2020)
10.2 Vasculitis Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Vasculitis Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Vasculitis Treatment Market Size by Application (2015-2020)
11 India
11.1 India Vasculitis Treatment Market Size (2015-2020)
11.2 Vasculitis Treatment Key Players in India (2019-2020)
11.3 India Vasculitis Treatment Market Size by Type (2015-2020)
11.4 India Vasculitis Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Vasculitis Treatment Market Size (2015-2020)
12.2 Vasculitis Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Vasculitis Treatment Market Size by Type (2015-2020)
12.4 Central & South America Vasculitis Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbvie
13.1.1 Abbvie Company Details
13.1.2 Abbvie Business Overview
13.1.3 Abbvie Vasculitis Treatment Introduction
13.1.4 Abbvie Revenue in Vasculitis Treatment Business (2015-2020))
13.1.5 Abbvie Recent Development
13.2 Ablynx
13.2.1 Ablynx Company Details
13.2.2 Ablynx Business Overview
13.2.3 Ablynx Vasculitis Treatment Introduction
13.2.4 Ablynx Revenue in Vasculitis Treatment Business (2015-2020)
13.2.5 Ablynx Recent Development
13.3 Amgen
13.3.1 Amgen Company Details
13.3.2 Amgen Business Overview
13.3.3 Amgen Vasculitis Treatment Introduction
13.3.4 Amgen Revenue in Vasculitis Treatment Business (2015-2020)
13.3.5 Amgen Recent Development
13.4 Anthera Pharmaceuticals
13.4.1 Anthera Pharmaceuticals Company Details
13.4.2 Anthera Pharmaceuticals Business Overview
13.4.3 Anthera Pharmaceuticals Vasculitis Treatment Introduction
13.4.4 Anthera Pharmaceuticals Revenue in Vasculitis Treatment Business (2015-2020)
13.4.5 Anthera Pharmaceuticals Recent Development
13.5 Aspen Pharmacare Holdings
13.5.1 Aspen Pharmacare Holdings Company Details
13.5.2 Aspen Pharmacare Holdings Business Overview
13.5.3 Aspen Pharmacare Holdings Vasculitis Treatment Introduction
13.5.4 Aspen Pharmacare Holdings Revenue in Vasculitis Treatment Business (2015-2020)
13.5.5 Aspen Pharmacare Holdings Recent Development
13.6 Astrazeneca
13.6.1 Astrazeneca Company Details
13.6.2 Astrazeneca Business Overview
13.6.3 Astrazeneca Vasculitis Treatment Introduction
13.6.4 Astrazeneca Revenue in Vasculitis Treatment Business (2015-2020)
13.6.5 Astrazeneca Recent Development
13.7 Baxter
13.7.1 Baxter Company Details
13.7.2 Baxter Business Overview
13.7.3 Baxter Vasculitis Treatment Introduction
13.7.4 Baxter Revenue in Vasculitis Treatment Business (2015-2020)
13.7.5 Baxter Recent Development
13.8 Biogen
13.8.1 Biogen Company Details
13.8.2 Biogen Business Overview
13.8.3 Biogen Vasculitis Treatment Introduction
13.8.4 Biogen Revenue in Vasculitis Treatment Business (2015-2020)
13.8.5 Biogen Recent Development
13.9 Bristol-Myers Squibb
13.9.1 Bristol-Myers Squibb Company Details
13.9.2 Bristol-Myers Squibb Business Overview
13.9.3 Bristol-Myers Squibb Vasculitis Treatment Introduction
13.9.4 Bristol-Myers Squibb Revenue in Vasculitis Treatment Business (2015-2020)
13.9.5 Bristol-Myers Squibb Recent Development
13.10 Celgene
13.10.1 Celgene Company Details
13.10.2 Celgene Business Overview
13.10.3 Celgene Vasculitis Treatment Introduction
13.10.4 Celgene Revenue in Vasculitis Treatment Business (2015-2020)
13.10.5 Celgene Recent Development
13.11 Celltrion
10.11.1 Celltrion Company Details
10.11.2 Celltrion Business Overview
10.11.3 Celltrion Vasculitis Treatment Introduction
10.11.4 Celltrion Revenue in Vasculitis Treatment Business (2015-2020)
10.11.5 Celltrion Recent Development
13.12 Chemocentryx
10.12.1 Chemocentryx Company Details
10.12.2 Chemocentryx Business Overview
10.12.3 Chemocentryx Vasculitis Treatment Introduction
10.12.4 Chemocentryx Revenue in Vasculitis Treatment Business (2015-2020)
10.12.5 Chemocentryx Recent Development
13.13 Chugai Pharma Usa
10.13.1 Chugai Pharma Usa Company Details
10.13.2 Chugai Pharma Usa Business Overview
10.13.3 Chugai Pharma Usa Vasculitis Treatment Introduction
10.13.4 Chugai Pharma Usa Revenue in Vasculitis Treatment Business (2015-2020)
10.13.5 Chugai Pharma Usa Recent Development
13.14 Eisai
10.14.1 Eisai Company Details
10.14.2 Eisai Business Overview
10.14.3 Eisai Vasculitis Treatment Introduction
10.14.4 Eisai Revenue in Vasculitis Treatment Business (2015-2020)
10.14.5 Eisai Recent Development
13.15 Eli Lilly
10.15.1 Eli Lilly Company Details
10.15.2 Eli Lilly Business Overview
10.15.3 Eli Lilly Vasculitis Treatment Introduction
10.15.4 Eli Lilly Revenue in Vasculitis Treatment Business (2015-2020)
10.15.5 Eli Lilly Recent Development
13.16 F. Hoffmann-La Roche
10.16.1 F. Hoffmann-La Roche Company Details
10.16.2 F. Hoffmann-La Roche Business Overview
10.16.3 F. Hoffmann-La Roche Vasculitis Treatment Introduction
10.16.4 F. Hoffmann-La Roche Revenue in Vasculitis Treatment Business (2015-2020)
10.16.5 F. Hoffmann-La Roche Recent Development
13.17 Genentech
10.17.1 Genentech Company Details
10.17.2 Genentech Business Overview
10.17.3 Genentech Vasculitis Treatment Introduction
10.17.4 Genentech Revenue in Vasculitis Treatment Business (2015-2020)
10.17.5 Genentech Recent Development
13.18 Gilead
10.18.1 Gilead Company Details
10.18.2 Gilead Business Overview
10.18.3 Gilead Vasculitis Treatment Introduction
10.18.4 Gilead Revenue in Vasculitis Treatment Business (2015-2020)
10.18.5 Gilead Recent Development
13.19 Glaxosmithkline
10.19.1 Glaxosmithkline Company Details
10.19.2 Glaxosmithkline Business Overview
10.19.3 Glaxosmithkline Vasculitis Treatment Introduction
10.19.4 Glaxosmithkline Revenue in Vasculitis Treatment Business (2015-2020)
10.19.5 Glaxosmithkline Recent Development
13.20 Human Genome Sciences
10.20.1 Human Genome Sciences Company Details
10.20.2 Human Genome Sciences Business Overview
10.20.3 Human Genome Sciences Vasculitis Treatment Introduction
10.20.4 Human Genome Sciences Revenue in Vasculitis Treatment Business (2015-2020)
10.20.5 Human Genome Sciences Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Vasculitis Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Vasculitis Treatment Revenue
Table 3. Ranking of Global Top Vasculitis Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Vasculitis Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Large Vessels
Table 6. Key Players of Medium Vessels
Table 7. Key Players of Small Vessels
Table 8. Global Vasculitis Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Vasculitis Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Vasculitis Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Vasculitis Treatment Market Share by Regions (2015-2020)
Table 12. Global Vasculitis Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Vasculitis Treatment Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Vasculitis Treatment Market Growth Strategy
Table 18. Main Points Interviewed from Key Vasculitis Treatment Players
Table 19. Global Vasculitis Treatment Revenue by Players (2015-2020) (Million US$)
Table 20. Global Vasculitis Treatment Market Share by Players (2015-2020)
Table 21. Global Top Vasculitis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vasculitis Treatment as of 2019)
Table 22. Global Vasculitis Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Vasculitis Treatment Product Solution and Service
Table 25. Date of Enter into Vasculitis Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Vasculitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 28. Global Vasculitis Treatment Market Size Share by Type (2015-2020)
Table 29. Global Vasculitis Treatment Revenue Market Share by Type (2021-2026)
Table 30. Global Vasculitis Treatment Market Size Share by Application (2015-2020)
Table 31. Global Vasculitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 32. Global Vasculitis Treatment Market Size Share by Application (2021-2026)
Table 33. North America Key Players Vasculitis Treatment Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Vasculitis Treatment Market Share (2019-2020)
Table 35. North America Vasculitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 36. North America Vasculitis Treatment Market Share by Type (2015-2020)
Table 37. North America Vasculitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. North America Vasculitis Treatment Market Share by Application (2015-2020)
Table 39. Europe Key Players Vasculitis Treatment Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Vasculitis Treatment Market Share (2019-2020)
Table 41. Europe Vasculitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Vasculitis Treatment Market Share by Type (2015-2020)
Table 43. Europe Vasculitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Vasculitis Treatment Market Share by Application (2015-2020)
Table 45. China Key Players Vasculitis Treatment Revenue (2019-2020) (Million US$)
Table 46. China Key Players Vasculitis Treatment Market Share (2019-2020)
Table 47. China Vasculitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. China Vasculitis Treatment Market Share by Type (2015-2020)
Table 49. China Vasculitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. China Vasculitis Treatment Market Share by Application (2015-2020)
Table 51. Japan Key Players Vasculitis Treatment Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Vasculitis Treatment Market Share (2019-2020)
Table 53. Japan Vasculitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Vasculitis Treatment Market Share by Type (2015-2020)
Table 55. Japan Vasculitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Vasculitis Treatment Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Vasculitis Treatment Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Vasculitis Treatment Market Share (2019-2020)
Table 59. Southeast Asia Vasculitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Vasculitis Treatment Market Share by Type (2015-2020)
Table 61. Southeast Asia Vasculitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Vasculitis Treatment Market Share by Application (2015-2020)
Table 63. India Key Players Vasculitis Treatment Revenue (2019-2020) (Million US$)
Table 64. India Key Players Vasculitis Treatment Market Share (2019-2020)
Table 65. India Vasculitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 66. India Vasculitis Treatment Market Share by Type (2015-2020)
Table 67. India Vasculitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 68. India Vasculitis Treatment Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Vasculitis Treatment Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Vasculitis Treatment Market Share (2019-2020)
Table 71. Central & South America Vasculitis Treatment Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Vasculitis Treatment Market Share by Type (2015-2020)
Table 73. Central & South America Vasculitis Treatment Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Vasculitis Treatment Market Share by Application (2015-2020)
Table 75. Abbvie Company Details
Table 76. Abbvie Business Overview
Table 77. Abbvie Product
Table 78. Abbvie Revenue in Vasculitis Treatment Business (2015-2020) (Million US$)
Table 79. Abbvie Recent Development
Table 80. Ablynx Company Details
Table 81. Ablynx Business Overview
Table 82. Ablynx Product
Table 83. Ablynx Revenue in Vasculitis Treatment Business (2015-2020) (Million US$)
Table 84. Ablynx Recent Development
Table 85. Amgen Company Details
Table 86. Amgen Business Overview
Table 87. Amgen Product
Table 88. Amgen Revenue in Vasculitis Treatment Business (2015-2020) (Million US$)
Table 89. Amgen Recent Development
Table 90. Anthera Pharmaceuticals Company Details
Table 91. Anthera Pharmaceuticals Business Overview
Table 92. Anthera Pharmaceuticals Product
Table 93. Anthera Pharmaceuticals Revenue in Vasculitis Treatment Business (2015-2020) (Million US$)
Table 94. Anthera Pharmaceuticals Recent Development
Table 95. Aspen Pharmacare Holdings Company Details
Table 96. Aspen Pharmacare Holdings Business Overview
Table 97. Aspen Pharmacare Holdings Product
Table 98. Aspen Pharmacare Holdings Revenue in Vasculitis Treatment Business (2015-2020) (Million US$)
Table 99. Aspen Pharmacare Holdings Recent Development
Table 100. Astrazeneca Company Details
Table 101. Astrazeneca Business Overview
Table 102. Astrazeneca Product
Table 103. Astrazeneca Revenue in Vasculitis Treatment Business (2015-2020) (Million US$)
Table 104. Astrazeneca Recent Development
Table 105. Baxter Company Details
Table 106. Baxter Business Overview
Table 107. Baxter Product
Table 108. Baxter Revenue in Vasculitis Treatment Business (2015-2020) (Million US$)
Table 109. Baxter Recent Development
Table 110. Biogen Business Overview
Table 111. Biogen Product
Table 112. Biogen Company Details
Table 113. Biogen Revenue in Vasculitis Treatment Business (2015-2020) (Million US$)
Table 114. Biogen Recent Development
Table 115. Bristol-Myers Squibb Company Details
Table 116. Bristol-Myers Squibb Business Overview
Table 117. Bristol-Myers Squibb Product
Table 118. Bristol-Myers Squibb Revenue in Vasculitis Treatment Business (2015-2020) (Million US$)
Table 119. Bristol-Myers Squibb Recent Development
Table 120. Celgene Company Details
Table 121. Celgene Business Overview
Table 122. Celgene Product
Table 123. Celgene Revenue in Vasculitis Treatment Business (2015-2020) (Million US$)
Table 124. Celgene Recent Development
Table 125. Celltrion Company Details
Table 126. Celltrion Business Overview
Table 127. Celltrion Product
Table 128. Celltrion Revenue in Vasculitis Treatment Business (2015-2020) (Million US$)
Table 129. Celltrion Recent Development
Table 130. Chemocentryx Company Details
Table 131. Chemocentryx Business Overview
Table 132. Chemocentryx Product
Table 133. Chemocentryx Revenue in Vasculitis Treatment Business (2015-2020) (Million US$)
Table 134. Chemocentryx Recent Development
Table 135. Chugai Pharma Usa Company Details
Table 136. Chugai Pharma Usa Business Overview
Table 137. Chugai Pharma Usa Product
Table 138. Chugai Pharma Usa Revenue in Vasculitis Treatment Business (2015-2020) (Million US$)
Table 139. Chugai Pharma Usa Recent Development
Table 140. Eisai Company Details
Table 141. Eisai Business Overview
Table 142. Eisai Product
Table 143. Eisai Revenue in Vasculitis Treatment Business (2015-2020) (Million US$)
Table 144. Eisai Recent Development
Table 145. Eli Lilly Company Details
Table 146. Eli Lilly Business Overview
Table 147. Eli Lilly Product
Table 148. Eli Lilly Revenue in Vasculitis Treatment Business (2015-2020) (Million US$)
Table 149. Eli Lilly Recent Development
Table 150. F. Hoffmann-La Roche Company Details
Table 151. F. Hoffmann-La Roche Business Overview
Table 152. F. Hoffmann-La Roche Product
Table 153. F. Hoffmann-La Roche Revenue in Vasculitis Treatment Business (2015-2020) (Million US$)
Table 154. F. Hoffmann-La Roche Recent Development
Table 155. Genentech Company Details
Table 156. Genentech Business Overview
Table 157. Genentech Product
Table 158. Genentech Revenue in Vasculitis Treatment Business (2015-2020) (Million US$)
Table 159. Genentech Recent Development
Table 160. Gilead Company Details
Table 161. Gilead Business Overview
Table 162. Gilead Product
Table 163. Gilead Revenue in Vasculitis Treatment Business (2015-2020) (Million US$)
Table 164. Gilead Recent Development
Table 165. Glaxosmithkline Company Details
Table 166. Glaxosmithkline Business Overview
Table 167. Glaxosmithkline Product
Table 168. Glaxosmithkline Revenue in Vasculitis Treatment Business (2015-2020) (Million US$)
Table 169. Glaxosmithkline Recent Development
Table 170. Human Genome Sciences Company Details
Table 171. Human Genome Sciences Business Overview
Table 172. Human Genome Sciences Product
Table 173. Human Genome Sciences Revenue in Vasculitis Treatment Business (2015-2020) (Million US$)
Table 174. Human Genome Sciences Recent Development
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Vasculitis Treatment Market Share by Type: 2020 VS 2026
Figure 2. Large Vessels Features
Figure 3. Medium Vessels Features
Figure 4. Small Vessels Features
Figure 5. Global Vasculitis Treatment Market Share by Application: 2020 VS 2026
Figure 6. Hospitals And Clinics Case Studies
Figure 7. Diagnosis Center Case Studies
Figure 8. Research Institutes Case Studies
Figure 9. Others Case Studies
Figure 10. Vasculitis Treatment Report Years Considered
Figure 11. Global Vasculitis Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Vasculitis Treatment Market Share by Regions: 2020 VS 2026
Figure 13. Global Vasculitis Treatment Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Vasculitis Treatment Market Share by Players in 2019
Figure 16. Global Top Vasculitis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vasculitis Treatment as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Vasculitis Treatment Revenue in 2019
Figure 18. North America Vasculitis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Vasculitis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Vasculitis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Vasculitis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Vasculitis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Vasculitis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Vasculitis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
ANCA関連血管炎薬の世界市場（～2026年） Market Analysis and Insights: Global Anca Vasculitis Drug Market The global Anca Vasculitis Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Anca Vasculitis Drug Scope and Market Size Anca Vasculitis Drug market is…- 血管炎治療薬の世界市場（～2026年） Market Analysis and Insights: Global Vasculitis Drug Market The global Vasculitis Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Vasculitis Drug Scope and Market Size Vasculitis Drug market is segmented by Type, …
- 内陸水路船の世界市場（～2026年） Inland Waterways Transport is an important industry contributing to growth of goods transport through waterways. Due to the benefits of reliability and congestion-free transportation of inland waterways. Passengers ships or non-passenger vessels are prone to be transported through inland waterways. …
- フローティング（重量物リフト）設置船の世界市場（～2026年） Market Analysis and Insights: Global Floating (Heavy Lift ) Installation Vessels Market The global Floating (Heavy Lift ) Installation Vessels market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in …
- ミトコンドリアミオパチー診断・治療の世界市場（～2026年） Mitochondrial myopathies are types of myopathies associated with mitochondrial disease. On biopsy, the muscle tissue of patients with these diseases usually demonstrate "ragged red" muscle fibers. These ragged-red fibers contain mild accumulations of glycogen and neutral lipids, and may show an incr…